Summary

U.S. Animal Wound Care Market Summary

The U.S. animal wound care market size was estimated at USD 316.2 million in 2024 and is projected to reach USD 466.0 million by 2030, growing at a CAGR of 6.8% from 2025 to 2030. This growth is driven by the rising ownership and humanization of companion animals, which has elevated demand for high-quality veterinary care.

Pet owners increasingly view animals as family members, prioritizing their health and well-being. This shift has amplified the need for effective wound management, post-surgical recovery, and routine care. According to the American Veterinary Medical Association (2024), 45.5% of U.S. households owned a dog and 32.1% owned a cat, highlighting the substantial pet population driving demand for veterinary wound care nationwide. As owners become more financially prepared to invest in preventive and therapeutic care, the utilization of advanced wound care products has surged. The expansion of veterinary service networks also contributes to improved market penetration, which in turn supports sustained product demand across both urban and rural markets.

There is a notable shift in preference from basic wound management products to advanced solutions that promote faster healing and superior clinical outcomes. Products incorporating antimicrobial agents, hypochlorous acid (HOCl), and regenerative technologies are gaining traction among veterinary professionals. These innovations reduce the risk of infection, minimize animal discomfort, and offer ease of application in various care settings. The growing emphasis on evidence-based, efficient care drives adoption among clinics and pet owners. This demand is further reinforced by ongoing R&D and product diversification by market participants.

U.S. Animal Wound Care Market Report Segmentation

This report forecasts revenue growth at the country level and analyzes the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. animal wound care market report based on product, animal type, distribution channel, and end use.

• Product Outlook (Revenue, USD Million, 2018 - 2030)
• Surgical Wound Care Products
o Sutures & staplers
o Tissue Adhesive
• Advanced Wound Care Products
o Foam Dressings
o Hydrocolloid dressing
o Film Dressing
o Hydrogel Dressing
o Others
• Traditional Wound Care Products
o Tapes
o Bandages
o Dressing
o Absorbents
o Others
• Therapy Devices
• Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
• Companion Animal
o Dogs
o Cats
o Horses
o Other (small mammals, birds)
• Livestock Animal
• Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
• Retail
• E-commerce
• Veterinary Hospitals/Clinics
• End Use Outlook (Revenue, USD Million, 2018 - 2030)
• Veterinary Hospitals/Clinics
• Homecare
• Research Institutes

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources and Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation and Data Visualization
1.6. Data Validation and Publishing
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. U.S. Animal Wound Care Market Variables, Trends, and Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.2.3. Industry Challenge
3.3. Industry Analysis Tools
3.3.1. PORTER’s Analysis
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and social landscape
3.3.2.3. Technological landscape
Chapter 4. U.S. Animal Wound Care Market: Product Estimates and Trend Analysis
4.1. U.S. Animal Wound Care Market, By Product: Key Takeaways
4.2. Product Movement Analysis and Market Share, 2024 and 2030
4.3. Market Estimates and Forecasts, By Product, 2018 - 2030 (USD Million)
4.3.1. Surgical Wound Care Products
4.3.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.1.2. Sutures & staplers
4.3.1.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.1.3. Tissue Adhesive
4.3.1.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2. Advanced Wound Care Products
4.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2.2. Foam Dressings
4.3.2.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2.3. Hydrocolloid dressing
4.3.2.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2.4. Film Dressing
4.3.2.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2.5. Hydrogel Dressing
4.3.2.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2.6. Others
4.3.2.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3. Traditional Wound Care Products
4.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.2. Tapes
4.3.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.3. Bandages
4.3.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.4. Dressing
4.3.3.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.5. Absorbants
4.3.3.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.6. Others
4.3.3.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.4. Therapy Devices
4.3.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. U.S. Animal Wound Care Market: Animal Type Estimates and Trend Analysis
5.1. U.S. Animal Wound Care Market, By Animal Type: Key Takeaways
5.2. Animal Type Movement Analysis and Market Share, 2024 and 2030
5.3. Market Estimates and Forecasts, By Animal Type, 2018 - 2030 (USD Million)
5.3.1. Companion Animal
5.3.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.1.2. Dogs
5.3.1.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.1.3. Cats
5.3.1.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.1.4. Horses
5.3.1.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.1.5. Other (small mammals, birds)
5.3.1.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2. Livestock Animal
5.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. U.S. Animal Wound Care Market: Distribution Channel Estimates and Trend Analysis
6.1. U.S. Animal Wound Care Market, By Animal Type: Key Takeaways
6.2. Animal Type Movement Analysis and Market Share, 2024 and 2030
6.3. Market Estimates and Forecasts, By Animal Type, 2018 - 2030 (USD Million)
6.3.1. Retail
6.3.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. E-commerce
6.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. Veterinary Hospitals/Clinics
6.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. U.S. Animal Wound Care Market: End Use Estimates and Trend Analysis
7.1. U.S. Animal Wound Care Market, By End Use: Key Takeaways
7.2. End Use Movement Analysis and Market Share, 2024 and 2030
7.3. Market Estimates and Forecasts, By End Use, 2018 - 2030 (USD Million)
7.3.1. Veterinary Hospitals/Clinics
7.3.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. Homecare
7.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Research Institutes
7.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Company Market Positioning
8.3. Company Heat Map Analysis
8.4. Company Profiles/Listing
8.4.1. 3M
8.4.1.1. Company Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Portfolio
8.4.1.4. Recent Developments/ Strategic Initiatives
8.4.2. Johnson & Johnson
8.4.2.1. Company Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Portfolio
8.4.2.4. Recent Developments/ Strategic Initiatives
8.4.3. Merck & Co., Inc
8.4.3.1. Company Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Portfolio
8.4.3.4. Recent Developments/ Strategic Initiatives
8.4.4. Virbac
8.4.4.1. Company Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Portfolio
8.4.4.4. Recent Developments/ Strategic Initiatives
8.4.5. Neogen Corporation
8.4.5.1. Company Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Portfolio
8.4.5.4. Recent Developments/ Strategic Initiatives
8.4.6. INNOVACYN, INC.
8.4.6.1. Company Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Portfolio
8.4.6.4. Recent Developments/ Strategic Initiatives
8.4.7. KeriCure Inc.
8.4.7.1. Company Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Portfolio
8.4.7.4. Recent Developments/ Strategic Initiatives
8.4.8. Zoetis Services LLC
8.4.8.1. Company Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Portfolio
8.4.8.4. Recent Developments/ Strategic Initiatives